Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon;Prevalência da infecção e de portadores do vírus da hepatite B, após 19 anos do programa de vacinação na Amazônia ocidental Brasileira

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 45, Issue 1, 2012, Pages 13-17

  Braga, Wornei Silva Miranda ^a,b   da Costa Castilho, Márcia ^a,b   Borges, Fabiane Giovanella ^a   de Souza Martinho, Ana Cristina ^a   Rodrigues, Ivo Seixas ^a   de Azevedo, Eliete Pereira ^a   Scazufca, Márcia ^c   Menezes, Paulo Rossi ^c  

^a FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^b UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Epidemiology; HBV; Hepatitis B; Prevalence; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PUBLIC HEALTH; RURAL AREA; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE;

ADOLESCENT; BRAZIL; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; PREVALENCE; PROGRAM EVALUATION; RURAL POPULATION; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84857929407     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822012000100004     Document Type: Article

References (29)

1. World Health Organization. Hepatitis B. Fact sheet no. 204. Geneva, Switzerland: World Health Organization; 2000; [cited 2011 May 5]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/index.html.
2. Hipgrave DB, Nguyen TU, Hoang TL, Do TD, Tran NT, Jolley D, et al. Hepatitis B infection in rural Vietnam and implications for a national program of infant immunization. Am J Trop Hyg 2003; 69:288-294.
3. Kiire CF. The epidemiology and prophylaxis of Hepatitis B in sub-Saharan Africa: a view from tropical and sub-tropical areas. Gut 1996; 38:S5-12.
4. Vogt TM, Goldstein ST, Kuartei S. Endemic hepatitis B virus infection and chronic liver disease mortality in the republic of Palau, 1990-2002. Trans R Soc Trop Med Hyg 2006;100:1130-1134.
5. Bensabath G, Hadler SC, Pereira Soares MC, Fields H, Dias LB, Popper H, et al. Hepatitis Delta virus infection and Lábrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon basin. JAMA 1987; 258:479-483
6. Fonseca JFC, Simonetti SRR, Schatzmayr HG, Castejón MJ, Cesário ALO, Simonetti JP. Prevalence of infection with hepatitis delta virus (HDV) among carriers of hepatitis B surface antigen in Amazon State, Brazil. Trans R Soc Trop Med Hyg1988; 82:469-471.
7. Mac Mahon BJ, Schoemberg S, Blkow L, Wainwright RB, Fitzerald MA, Parkinson AJ, et al. Seroprevalence of hepatitis B viral markers in 52,000 Alaska natives. Am J Epidemiol 1993; 138:544-549.
8. Vardas E, Mathai M, Blaau D, McAnerney J, Coppin A, Sim J. Preimmunisation epidemiology of hepatitis B virus infection in South African children. J Med Virol 1999; 58:111-115.
9. Chang MH. Natural history of hepatitis B virus infection in children. J Gastroenterol Hepatol 2000; 15:E16-19.
10. Brasil LM, Fonseca JC, Souza RB, Braga WS, Toledo LM. Prevalência de marcadores para o vírus da hepatite B em contatos domiciliares no Estado do Amazonas. Rev Soc Bras Med Trop 2003; 36:565-570.
11. Brabin L, Brabin BJ. Cultural factors and transmission of hepatitis B virus. Am J Epidemiol 1985; 122:725-730.
12. Bensabath G, Boshel J. Presença do antígeno "Austrália" (Ag) em populaces do interior do Estado do Amazonas-Brasil. Rev Inst Med Trop Sao Paulo 1973; 15:284-288.
13. Hadler SC, Monzon M, Ponzetto A, Anzola E, Rivero D, Mondolfi A, et al. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med 1984; 100:339-344.
14. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med1997; 336:1855-1859.
15. Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G, et al. Elimination of new chronic hepatitis B virus infections: Results of the Alaska immunization program. J Infect Dis 2000; 181:413-418.
16. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135:796-800.
17. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: A historical overview. Vaccine 2008; 26:6266-6273.
18. Instituto Brasileiro de Geografia e Estatística. Database of information by census tract; 2000; [cited 2011 May 5]. Available from: http://www.ibge.gov.br/cidadesat/default.php/.
19. Braga WSM, Brasil LM, Souza RAB, Melo MS, Rosas MDG, Castilho MC, et al. Prevalência da infecção pelos vírus da hepatite B (VHB) e da hepatite D (VHD) em Lábrea, Rio Purus, Estado do Amazonas. Epidemiol Serv Saude 2004; 13:35-46.
20. TM statistical software[computer programm].Version 3.3.2. Atlanta GA: Centers for Diesease Control and Prevention; 2005.
21. Statacorp. Stata Statistical software. [computer programm]. Release IC 10.0. College Station, TX: Statacorp; 2006.
22. Hoz F, Perez L, Neira M, Hall AJ. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B infection and effectiveness. Int J Infect Dis 2008;12:183-189.
23. Alecrim WD, Marreiros LS, Alecrim MGC, Miranda-Santos IKF. Inquérito sobre presença de HBsAg em habitantes de Lábrea-Amazonas. Rev Soc Bras Med Trop 1986; 19:58-59.
24. Bensabath G, Hadler SC, Soares MCP, Fields H, Dias LB, Popper H, et al. Epidemiologic and serologic studies of acute viral hepatitis in Brazil ́s Amazon Basin. Bull Pan Am Health Organ 1987; 21:16-27.
25. Sullivan JS, Hanna JN. A genetic marker associated with non-response to recombinant hepatitis B vaccine by indigenous Australian children. J Paediatr Child Health 1999; 35:412-413.
26. Villa G, Romano L, Sepe A, Lorio R, Paribello N, Zappa A, et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 2007;25:3133-3136.
27. Chen CC, Yen CH, Wu WY, Hu SW, Chen SC, Bell WR, et al. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program. Chin Med J 2007;120:1155-1158.
28. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 2001; 19:3919-3926.
29. Scotto J, Hadchouel M, Hery C, Yvart J, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. Hepatology1983; 3:279-284.